TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 NOK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
1,252
|
756
|
486 |
Financial expenses |
440
|
413
|
4 |
Earnings before taxes |
97
|
67
|
-91 |
EBITDA |
537
|
469
|
-111 |
Total assets |
14,903
|
14,683
|
15,362 |
Current assets |
1,152
|
907
|
702 |
Current liabilities |
386
|
263
|
166 |
Equity capital |
14,408
|
14,304
|
15,061 |
- share capital |
99
|
97
|
101 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
96.7%
|
97.4%
|
98.0% |
Turnover per employee |
1,252
|
756
|
486 |
Profit as a percentage of turnover |
7.7%
|
8.9%
|
-18.7% |
Return on assets (ROA) |
3.6%
|
3.3%
|
-0.6% |
Current ratio |
298.4%
|
344.9%
|
422.9% |
Return on equity (ROE) |
0.7%
|
0.5%
|
-0.6% |
Change turnover |
479
|
288
|
-121 |
Change turnover % |
62%
|
61%
|
-20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.